Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.

Ssemaganda A, Giddam AK, Zaman M, Skwarczynski M, Toth I, Stanisic DI, Good MF.

Front Immunol. 2019 Feb 1;10:135. doi: 10.3389/fimmu.2019.00135. eCollection 2019. Review.

2.

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.

He WQ, Shakri AR, Bhardwaj R, França CT, Stanisic DI, Healer J, Kiniboro B, Robinson LJ, Guillotte-Blisnick M, Huon C, Siba P, Cowman A, King CL, Tham WH, Chitnis CE, Mueller I.

PLoS Negl Trop Dis. 2019 Feb 15;13(2):e0006987. doi: 10.1371/journal.pntd.0006987. eCollection 2019 Feb.

3.

Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.

Low LM, Ssemaganda A, Liu XQ, Ho MF, Ozberk V, Fink J, Sundac L, Alcorn K, Morrison A, O'Callaghan K, Gerrard J, Stanisic DI, Good MF.

Infect Immun. 2018 Dec 19;87(1). pii: e00587-18. doi: 10.1128/IAI.00587-18. Print 2019 Jan.

4.

Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.

Stanisic DI, Fink J, Mayer J, Coghill S, Gore L, Liu XQ, El-Deeb I, Rodriguez IB, Powell J, Willemsen NM, De SL, Ho MF, Hoffman SL, Gerrard J, Good MF.

BMC Med. 2018 Oct 8;16(1):184. doi: 10.1186/s12916-018-1173-9.

5.

Iron deficiency during pregnancy is associated with a reduced risk of adverse birth outcomes in a malaria-endemic area in a longitudinal cohort study.

Fowkes FJI, Moore KA, Opi DH, Simpson JA, Langham F, Stanisic DI, Ura A, King CL, Siba PM, Mueller I, Rogerson SJ, Beeson JG.

BMC Med. 2018 Sep 20;16(1):156. doi: 10.1186/s12916-018-1146-z.

6.

Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulation.

Reiman JM, Kumar S, Rodriguez IB, Gnidehou S, Ito K, Stanisic DI, Lee M, McPhun V, Majam V, Willemsen NM, Batzloff MR, Raja AI, Dooley B, Hoffman SL, Yanow SK, Good MF.

Clin Transl Immunology. 2018 Apr 11;7(4):e1015. doi: 10.1002/cti2.1015. eCollection 2018.

7.

Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.

Feng G, Boyle MJ, Cross N, Chan JA, Reiling L, Osier F, Stanisic DI, Mueller I, Anders RF, McCarthy JS, Richards JS, Beeson JG.

J Infect Dis. 2018 Jun 5;218(1):35-43. doi: 10.1093/infdis/jiy170.

PMID:
29584918
8.

Gold(i) phosphine compounds as parasite attenuating agents for malaria vaccine and drug development.

Ssemaganda A, Low LM, Verhoeft KR, Wambuzi M, Kawoozo B, Nabasumba SB, Mpendo J, Bagaya BS, Kiwanuka N, Stanisic DI, Berners-Price SJ, Good MF.

Metallomics. 2018 Mar 1;10(3):444-454. doi: 10.1039/c7mt00311k. Epub 2018 Feb 21.

PMID:
29465117
9.

Exploiting the apicoplast: apicoplast-targeting drugs and malaria vaccine development.

Low LM, Stanisic DI, Good MF.

Microbes Infect. 2018 Oct - Nov;20(9-10):477-483. doi: 10.1016/j.micinf.2017.12.005. Epub 2017 Dec 26.

PMID:
29287981
10.

Controlled Human Malaria Infection: Applications, Advances, and Challenges.

Stanisic DI, McCarthy JS, Good MF.

Infect Immun. 2017 Dec 19;86(1). pii: e00479-17. doi: 10.1128/IAI.00479-17. Print 2018 Jan. Review.

11.

Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.

Chan JA, Stanisic DI, Duffy MF, Robinson LJ, Lin E, Kazura JW, King CL, Siba PM, Fowkes FJ, Mueller I, Beeson JG.

Eur J Immunol. 2017 Dec;47(12):2124-2136. doi: 10.1002/eji.201747032. Epub 2017 Sep 13.

12.

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

Raja AI, Stanisic DI, Good MF.

Infect Immun. 2017 Jun 20;85(7). pii: e00062-17. doi: 10.1128/IAI.00062-17. Print 2017 Jul. Review.

13.

Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite.

Stanisic DI, Gerrard J, Fink J, Griffin PM, Liu XQ, Sundac L, Sekuloski S, Rodriguez IB, Pingnet J, Yang Y, Zhou Y, Trenholme KR, Wang CY, Hackett H, Chan JA, Langer C, Hanssen E, Hoffman SL, Beeson JG, McCarthy JS, Good MF.

Infect Immun. 2016 Aug 19;84(9):2689-96. doi: 10.1128/IAI.00414-16. Print 2016 Sep.

14.

Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection.

Raja AI, Cai Y, Reiman JM, Groves P, Chakravarty S, McPhun V, Doolan DL, Cockburn I, Hoffman SL, Stanisic DI, Good MF.

Infect Immun. 2016 Jul 21;84(8):2274-2288. doi: 10.1128/IAI.00157-16. Print 2016 Aug.

15.

Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys.

De SL, Stanisic DI, van Breda K, Bellete B, Harris I, McCallum F, Edstein MD, Good MF.

Int J Parasitol. 2016 Aug;46(9):581-91. doi: 10.1016/j.ijpara.2016.05.002. Epub 2016 May 26.

PMID:
27238088
16.

A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.

Chan JA, Howell KB, Langer C, Maier AG, Hasang W, Rogerson SJ, Petter M, Chesson J, Stanisic DI, Duffy MF, Cooke BM, Siba PM, Mueller I, Bull PC, Marsh K, Fowkes FJ, Beeson JG.

Cell Mol Life Sci. 2016 Nov;73(21):4141-58. doi: 10.1007/s00018-016-2267-1. Epub 2016 May 19.

17.

Examining cellular immune responses to inform development of a blood-stage malaria vaccine.

Stanisic DI, Good MF.

Parasitology. 2016 Feb;143(2):208-23. doi: 10.1017/S0031182015001092. Epub 2016 Jan 8. Review.

PMID:
26743398
18.

Plasmodium berghei bio-burden correlates with parasite lactate dehydrogenase: application to murine Plasmodium diagnostics.

De SL, Stanisic DI, Rivera F, Batzloff MR, Engwerda C, Good MF.

Malar J. 2016 Jan 4;15:3. doi: 10.1186/s12936-015-1027-2.

19.

Evaluation of the 2-Aminomethylphenol JPC-2997 in Aotus Monkeys Infected with Plasmodium falciparum.

McCallum F, Harris I, van Breda K, De SL, Stanisic DI, Good MF, Jacobus DP, Edstein MD.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1948-9. doi: 10.1128/AAC.02799-15. No abstract available.

20.

A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children.

Manning L, Cutts J, Stanisic DI, Laman M, Carmagnac A, Allen S, O'Donnell A, Karunajeewa H, Rosanas-Urgell A, Siba P, Davis TM, Michon P, Schofield L, Rockett K, Kwiatkowski D, Mueller I.

Genes Immun. 2016 Jan-Feb;17(1):52-9. doi: 10.1038/gene.2015.50. Epub 2015 Dec 3.

PMID:
26633000
21.

Whole organism blood stage vaccines against malaria.

Stanisic DI, Good MF.

Vaccine. 2015 Dec 22;33(52):7469-75. doi: 10.1016/j.vaccine.2015.09.057. Epub 2015 Oct 1. Review.

22.

Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens.

Reddy SB, Anders RF, Cross N, Mueller I, Senn N, Stanisic DI, Siba PM, Wahlgren M, Kironde F, Beeson JG, Persson KE.

BMC Microbiol. 2015 Jul 3;15:133. doi: 10.1186/s12866-015-0461-1.

23.

Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines.

Stanisic DI, Liu XQ, De SL, Batzloff MR, Forbes T, Davis CB, Sekuloski S, Chavchich M, Chung W, Trenholme K, McCarthy JS, Li T, Sim BK, Hoffman SL, Good MF.

Malar J. 2015 Apr 7;14:143. doi: 10.1186/s12936-015-0663-x.

24.

Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New Guinea.

Stanisic DI, Moore KA, Baiwog F, Ura A, Clapham C, King CL, Siba PM, Beeson JG, Mueller I, Fowkes FJ, Rogerson SJ.

Trans R Soc Trop Med Hyg. 2015 May;109(5):313-24. doi: 10.1093/trstmh/trv019. Epub 2015 Mar 10.

PMID:
25758854
25.

High numbers of circulating pigmented polymorphonuclear neutrophils as a prognostic marker for decreased birth weight during malaria in pregnancy.

Chua CL, Robinson LJ, Baiwog F, Stanisic DI, Hamilton JA, Brown GV, Rogerson SJ, Boeuf P.

Int J Parasitol. 2015 Feb;45(2-3):107-11. doi: 10.1016/j.ijpara.2014.12.002. Epub 2014 Dec 31.

PMID:
25555554
26.

Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.

Stanisic DI, Fowkes FJ, Koinari M, Javati S, Lin E, Kiniboro B, Richards JS, Robinson LJ, Schofield L, Kazura JW, King CL, Zimmerman P, Felger I, Siba PM, Mueller I, Beeson JG.

Infect Immun. 2015 Feb;83(2):646-60. doi: 10.1128/IAI.02398-14. Epub 2014 Nov 24.

27.

Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.

Terheggen U, Drew DR, Hodder AN, Cross NJ, Mugyenyi CK, Barry AE, Anders RF, Dutta S, Osier FH, Elliott SR, Senn N, Stanisic DI, Marsh K, Siba PM, Mueller I, Richards JS, Beeson JG.

BMC Med. 2014 Oct 16;12:183. doi: 10.1186/s12916-014-0183-5.

28.

Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria.

Finney OC, Danziger SA, Molina DM, Vignali M, Takagi A, Ji M, Stanisic DI, Siba PM, Liang X, Aitchison JD, Mueller I, Gardner MJ, Wang R.

Mol Cell Proteomics. 2014 Oct;13(10):2646-60. doi: 10.1074/mcp.M113.036632. Epub 2014 Jul 14.

29.

γδ T cells and CD14+ monocytes are predominant cellular sources of cytokines and chemokines associated with severe malaria.

Stanisic DI, Cutts J, Eriksson E, Fowkes FJ, Rosanas-Urgell A, Siba P, Laman M, Davis TM, Manning L, Mueller I, Schofield L.

J Infect Dis. 2014 Jul 15;210(2):295-305. doi: 10.1093/infdis/jiu083. Epub 2014 Feb 12.

PMID:
24523513
30.

Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.

Stanisic DI, Javati S, Kiniboro B, Lin E, Jiang J, Singh B, Meyer EV, Siba P, Koepfli C, Felger I, Galinski MR, Mueller I.

PLoS Negl Trop Dis. 2013 Nov 14;7(11):e2498. doi: 10.1371/journal.pntd.0002498. eCollection 2013 Nov.

31.

Escaping the immune system: How the malaria parasite makes vaccine development a challenge.

Stanisic DI, Barry AE, Good MF.

Trends Parasitol. 2013 Dec;29(12):612-22. doi: 10.1016/j.pt.2013.10.001. Epub 2013 Oct 29. Review.

PMID:
24176554
32.

Cross-species malaria immunity induced by chemically attenuated parasites.

Good MF, Reiman JM, Rodriguez IB, Ito K, Yanow SK, El-Deeb IM, Batzloff MR, Stanisic DI, Engwerda C, Spithill T, Hoffman SL, Lee M, McPhun V.

J Clin Invest. 2013 Jul 1. pii: 66634. doi: 10.1172/JCI66634. [Epub ahead of print]

33.

Does malaria affect placental development? Evidence from in vitro models.

Umbers AJ, Stanisic DI, Ome M, Wangnapi R, Hanieh S, Unger HW, Robinson LJ, Lufele E, Baiwog F, Siba PM, King CL, Beeson JG, Mueller I, Aplin JD, Glazier JD, Rogerson SJ.

PLoS One. 2013;8(1):e55269. doi: 10.1371/journal.pone.0055269. Epub 2013 Jan 31. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/4faa7351-837e-4531-a513-0ea80277017f.

34.

Placental infection with Plasmodium vivax: a histopathological and molecular study.

Mayor A, Bardají A, Felger I, King CL, Cisteró P, Dobaño C, Stanisic DI, Siba P, Wahlgren M, del Portillo H, Mueller I, Menéndez C, Ordi J, Rogerson S.

J Infect Dis. 2012 Dec 15;206(12):1904-10. doi: 10.1093/infdis/jis614. Epub 2012 Oct 10.

PMID:
23053630
35.
36.

Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study.

Rosanas-Urgell A, Lin E, Manning L, Rarau P, Laman M, Senn N, Grimberg BT, Tavul L, Stanisic DI, Robinson LJ, Aponte JJ, Dabod E, Reeder JC, Siba P, Zimmerman PA, Davis TM, King CL, Michon P, Mueller I.

PLoS Med. 2012;9(9):e1001305. doi: 10.1371/journal.pmed.1001305. Epub 2012 Sep 4.

37.

Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.

Betuela I, Rosanas-Urgell A, Kiniboro B, Stanisic DI, Samol L, de Lazzari E, Del Portillo HA, Siba P, Alonso PL, Bassat Q, Mueller I.

J Infect Dis. 2012 Dec 1;206(11):1771-80. doi: 10.1093/infdis/jis580. Epub 2012 Sep 10.

PMID:
22966124
38.

Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial.

Senn N, Rarau P, Stanisic DI, Robinson L, Barnadas C, Manong D, Salib M, Iga J, Tarongka N, Ley S, Rosanas-Urgell A, Aponte JJ, Zimmerman PA, Beeson JG, Schofield L, Siba P, Rogerson SJ, Reeder JC, Mueller I.

PLoS Med. 2012;9(3):e1001195. doi: 10.1371/journal.pmed.1001195. Epub 2012 Mar 27. Erratum in: PLoS Med. 2012 Jun;9(6). doi:10.1371/annotation/de06fdd3-c263-416c-8b5f-291f9c474558.

39.

Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation.

Umbers AJ, Boeuf P, Clapham C, Stanisic DI, Baiwog F, Mueller I, Siba P, King CL, Beeson JG, Glazier J, Rogerson SJ.

J Infect Dis. 2011 Feb 15;203(4):561-9. doi: 10.1093/infdis/jiq080. Epub 2011 Jan 7.

40.

Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia.

Richards JS, Stanisic DI, Fowkes FJ, Tavul L, Dabod E, Thompson JK, Kumar S, Chitnis CE, Narum DL, Michon P, Siba PM, Cowman AF, Mueller I, Beeson JG.

Clin Infect Dis. 2010 Oct 15;51(8):e50-60. doi: 10.1086/656413.

PMID:
20843207
41.

Robert Koch redux: malaria immunology in Papua New Guinea.

Stanisic DI, Mueller I, Betuela I, Siba P, Schofield L.

Parasite Immunol. 2010 Aug;32(8):623-32. doi: 10.1111/j.1365-3024.2010.01238.x. Review.

42.

Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.

Hommel M, Elliott SR, Soma V, Kelly G, Fowkes FJ, Chesson JM, Duffy MF, Bockhorst J, Avril M, Mueller I, Raiko A, Stanisic DI, Rogerson SJ, Smith JD, Beeson JG.

Infect Immun. 2010 May;78(5):1963-78. doi: 10.1128/IAI.01365-09. Epub 2010 Feb 16.

43.

Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.

Fernandez-Becerra C, Sanz S, Brucet M, Stanisic DI, Alves FP, Camargo EP, Alonso PL, Mueller I, del Portillo HA.

Malar J. 2010 Jan 21;9:29. doi: 10.1186/1475-2875-9-29.

44.

Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea.

Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, Richards JS, Beeson JG, Tavul L, Michon P, Mueller I, Schofield L.

Infect Immun. 2009 Jul;77(7):3033-43. doi: 10.1128/IAI.00211-09. Epub 2009 Apr 20.

45.

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.

Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.

Infect Immun. 2009 Mar;77(3):1165-74. doi: 10.1128/IAI.01129-08. Epub 2009 Jan 12.

46.

Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children.

D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, Michon P, Mueller I, Schofield L.

Clin Infect Dis. 2008 Dec 1;47(11):1380-7. doi: 10.1086/592971.

PMID:
18947328
47.

Artemether treatment of prepatent Schistosoma japonicum induces resistance to reinfection in association with reduced pathology.

Bartley PB, Glanfield A, Li Y, Stanisic DI, Duke M, Jones MK, McManus DP.

Am J Trop Med Hyg. 2008 Jun;78(6):929-35.

48.

Plasmodium strain determines dendritic cell function essential for survival from malaria.

Wykes MN, Liu XQ, Beattie L, Stanisic DI, Stacey KJ, Smyth MJ, Thomas R, Good MF.

PLoS Pathog. 2007 Jul;3(7):e96.

Supplemental Content

Loading ...
Support Center